---
figid: PMC3096649__pone.0019846.g007
figlink: /pmc/articles/PMC3096649/figure/pone-0019846-g007/
number: F7
caption: Globally, after ligand binding IGF1R can signal directly from the membrane
  (IGF1R signaling internalization-independent), with a major degree of IRS1/PI3K/AKT
  signaling activation and a smaller enhancement of the Ras/Raf/MEK/ERK signaling
  pathway, or, when internalized either by clathrin and/or caveolin-dependent mechanisms,
  it can signal from vesicles. In the case of clathrin-dependent endocytosis, IGF1R
  is recruited to CCPs through interaction of its cytoplasmic tails with the protein
  adaptor AP2, which in turn recruits clathrin to the plasma membrane and promotes
  its assembly into a lattice network. Through protein-protein interaction, clathrin
  and AP2 also bind several proteins of the endocytic machinery, such as dynamin,
  which regulates the fission of the CCPs with the consequent formation of CCVs, and
  GRB2, which recruits and binds the SOS protein and the IGF1R-phosphorylated protein
  Shc, activating the RAS/RAF/MEK/ERK and p38MAPK signaling pathways. To a lesser
  extent, it also activates the IRS1/PI3K/AKT signaling pathway. In the case of caveolin-dependent
  endocytosis, IGF1R is recruited to caveolae, promoting caveolin phosphorylation
  and the subsequent recruitment of dynamin, which promotes caveolar budding and the
  formation of cavicles. Cav-1 phosphorylation phosphorylates IRS-1, enhancing the
  activation of thePI3K/AKT signaling pathway. The thickness of the arrows indicates
  the prevalence of signaling pathway activation. CPMZ treatment inhibits the formation
  of CCP by inhibiting clathrin-heavy-chain conformations and MCB inhibits the formation
  of cavicles by depleting cholesterol, disrupting the caveolae.
pmcid: PMC3096649
papertitle: IGF1R Signaling in Ewing Sarcoma Is Shaped by Clathrin-/Caveolin-Dependent
  Endocytosis.
reftext: Ana Sofia Martins, et al. PLoS One. 2011;6(5):e19846.
pmc_ranked_result_index: '22236'
pathway_score: 0.9467011
filename: pone.0019846.g007.jpg
figtitle: IGF1R Signaling in Ewing Sarcoma Is Shaped by Clathrin-/Caveolin-Dependent
  Endocytosis
year: '2011'
organisms: Homo sapiens
ndex: aa1434f4-defb-11ea-99da-0ac135e8bacf
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC3096649__pone.0019846.g007.html
  '@type': Dataset
  description: Globally, after ligand binding IGF1R can signal directly from the membrane
    (IGF1R signaling internalization-independent), with a major degree of IRS1/PI3K/AKT
    signaling activation and a smaller enhancement of the Ras/Raf/MEK/ERK signaling
    pathway, or, when internalized either by clathrin and/or caveolin-dependent mechanisms,
    it can signal from vesicles. In the case of clathrin-dependent endocytosis, IGF1R
    is recruited to CCPs through interaction of its cytoplasmic tails with the protein
    adaptor AP2, which in turn recruits clathrin to the plasma membrane and promotes
    its assembly into a lattice network. Through protein-protein interaction, clathrin
    and AP2 also bind several proteins of the endocytic machinery, such as dynamin,
    which regulates the fission of the CCPs with the consequent formation of CCVs,
    and GRB2, which recruits and binds the SOS protein and the IGF1R-phosphorylated
    protein Shc, activating the RAS/RAF/MEK/ERK and p38MAPK signaling pathways. To
    a lesser extent, it also activates the IRS1/PI3K/AKT signaling pathway. In the
    case of caveolin-dependent endocytosis, IGF1R is recruited to caveolae, promoting
    caveolin phosphorylation and the subsequent recruitment of dynamin, which promotes
    caveolar budding and the formation of cavicles. Cav-1 phosphorylation phosphorylates
    IRS-1, enhancing the activation of thePI3K/AKT signaling pathway. The thickness
    of the arrows indicates the prevalence of signaling pathway activation. CPMZ treatment
    inhibits the formation of CCP by inhibiting clathrin-heavy-chain conformations
    and MCB inhibits the formation of cavicles by depleting cholesterol, disrupting
    the caveolae.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - MAPK11
  - RAF1
  - MAPK12
  - MAPK10
  - MAP2K2
  - BRAF
  - ARAF
  - MAPK9
  - SHE
  - MAPK13
  - GRB2
  - MAPK14
  - SHC1
  - MAP2K1
  - PIK3R3
  - PIK3CG
  - SOS1
  - MAPK8
  - IGF1R
  - PIK3CB
  - PIK3R5
  - RPS6KB1
  - RPS6KB2
  - MAPK1
  - PIK3CD
  - IRS1
  - IGF1
  - HRAS
  - PIK3CA
  - PIK3R6
  - AKT3
  - PIK3R4
  - SHC4
  - SHC3
  - NRAS
  - MAPK3
  - SOS2
  - KRAS
  - RORC
  - AKT1
  - SHC2
  - CLTB
  - CLTC
  - CLTA
  - AKT2
  - CAV1
  - TFAP2A
  - Cancer
  - Cardiomyopathy
  - Lung cancer
  - Noonan syndrome
genes:
- word: p38
  symbol: p38
  source: bioentities_symbol
  hgnc_symbol: MAPK11
  entrez: '5600'
- word: Raf
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: RAF1
  entrez: '5894'
- word: p38
  symbol: p38
  source: bioentities_symbol
  hgnc_symbol: MAPK12
  entrez: '6300'
- word: JNK
  symbol: JNK
  source: bioentities_symbol
  hgnc_symbol: MAPK10
  entrez: '5602'
- word: MEK1/2
  symbol: MEK2
  source: hgnc_alias_symbol
  hgnc_symbol: MAP2K2
  entrez: '5605'
- word: Raf
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: BRAF
  entrez: '673'
- word: Raf
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: ARAF
  entrez: '369'
- word: JNK
  symbol: JNK
  source: bioentities_symbol
  hgnc_symbol: MAPK9
  entrez: '5601'
- word: She
  symbol: SHE
  source: hgnc_symbol
  hgnc_symbol: SHE
  entrez: '126669'
- word: p38
  symbol: p38
  source: bioentities_symbol
  hgnc_symbol: MAPK13
  entrez: '5603'
- word: Grb2
  symbol: GRB2
  source: hgnc_symbol
  hgnc_symbol: GRB2
  entrez: '2885'
- word: p38
  symbol: p38
  source: bioentities_symbol
  hgnc_symbol: MAPK14
  entrez: '1432'
- word: Shc
  symbol: SHC
  source: bioentities_symbol
  hgnc_symbol: SHC1
  entrez: '6464'
- word: MEK1/2
  symbol: MEK1
  source: hgnc_alias_symbol
  hgnc_symbol: MAP2K1
  entrez: '5604'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R3
  entrez: '8503'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CG
  entrez: '5294'
- word: sos
  symbol: SOS
  source: bioentities_symbol
  hgnc_symbol: SOS1
  entrez: '6654'
- word: JNK
  symbol: JNK
  source: bioentities_symbol
  hgnc_symbol: MAPK8
  entrez: '5599'
- word: IGF1R
  symbol: IGF1R
  source: hgnc_symbol
  hgnc_symbol: IGF1R
  entrez: '3480'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CB
  entrez: '5291'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R5
  entrez: '23533'
- word: P70S6K
  symbol: P70S6K
  source: bioentities_symbol
  hgnc_symbol: RPS6KB1
  entrez: '6198'
- word: P70S6K
  symbol: P70S6K
  source: bioentities_symbol
  hgnc_symbol: RPS6KB2
  entrez: '6199'
- word: ERK1/2
  symbol: ERK2
  source: hgnc_alias_symbol
  hgnc_symbol: MAPK1
  entrez: '5594'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CD
  entrez: '5293'
- word: IRS1
  symbol: IRS1
  source: hgnc_symbol
  hgnc_symbol: IRS1
  entrez: '3667'
- word: IGF1
  symbol: IGF1
  source: hgnc_symbol
  hgnc_symbol: IGF1
  entrez: '3479'
- word: Ras
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: HRAS
  entrez: '3265'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CA
  entrez: '5290'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R6
  entrez: '146850'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT3
  entrez: '10000'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R4
  entrez: '30849'
- word: Shc
  symbol: SHC
  source: bioentities_symbol
  hgnc_symbol: SHC4
  entrez: '399694'
- word: Shc
  symbol: SHC
  source: bioentities_symbol
  hgnc_symbol: SHC3
  entrez: '53358'
- word: Ras
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: NRAS
  entrez: '4893'
- word: ERK1/2
  symbol: ERK1
  source: hgnc_alias_symbol
  hgnc_symbol: MAPK3
  entrez: '5595'
- word: sos
  symbol: SOS
  source: bioentities_symbol
  hgnc_symbol: SOS2
  entrez: '6655'
- word: Ras
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: KRAS
  entrez: '3845'
- word: TOR
  symbol: TOR
  source: hgnc_alias_symbol
  hgnc_symbol: RORC
  entrez: '6097'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT1
  entrez: '207'
- word: Shc
  symbol: SHC
  source: bioentities_symbol
  hgnc_symbol: SHC2
  entrez: '25759'
- word: clathrin
  symbol: Clathrin
  source: bioentities_symbol
  hgnc_symbol: CLTB
  entrez: '1212'
- word: clathrin
  symbol: Clathrin
  source: bioentities_symbol
  hgnc_symbol: CLTC
  entrez: '1213'
- word: clathrin
  symbol: Clathrin
  source: bioentities_symbol
  hgnc_symbol: CLTA
  entrez: '1211'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT2
  entrez: '208'
- word: cav1
  symbol: CAV1
  source: hgnc_symbol
  hgnc_symbol: CAV1
  entrez: '857'
- word: AP2
  symbol: AP-2
  source: hgnc_alias_symbol
  hgnc_symbol: TFAP2A
  entrez: '7020'
chemicals: []
diseases:
- word: Cancer
  source: ''
  identifier: ''
- word: Cardiomyopathy
  source: ''
  identifier: ''
- word: Lung cancer
  source: ''
  identifier: ''
- word: Noonan syndrome
  source: ''
  identifier: ''
figid_alias: PMC3096649__F7
redirect_from: /figures/PMC3096649__F7
figtype: Figure
---
